People news

Share this article:
AstraZeneca named Rich Fante president of the company's US business. Fante will replace Tony Zook, who was recently named president of MedImmune, in addition to his position as CEO of AstraZeneca North America and head of global marketing. Fante was previously vice president, brand strategy & portfolio operations, and led marketing efforts for all AstraZeneca brands in the US.
 
Contract-sales firm PDI has appointed Nancy Lurker as CEO and member of the company's board of directors, effective Nov. 18. Lurker was previously senior vice president and CMO for Novartis Pharmaceuticals Corp., where she launched several products including Exforge, Tekturna, Reclast and the Exelon Patch.
Share this article:
You must be a registered member of MMM to post a comment.

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.